Gabelli Funds’s Edwards Lifesciences EW Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2023
Q3 | – | Sell |
-166,455
| Closed | -$15.7M | – | 1144 |
|
|
2023
Q2 | $15.7M | Buy |
166,455
+44,975
| +37% | +$4.24M | 0.12% | 227 |
|
|
2023
Q1 | $10.1M | Buy |
121,480
+8,500
| +8% | +$703K | 0.08% | 320 |
|
|
2022
Q4 | $8.43M | Buy |
+112,980
| New | +$8.43M | 0.07% | 341 |
|
|
2022
Q3 | – | Sell |
-360,117
| Closed | -$34.2M | – | 1361 |
|
|
2022
Q2 | $34.2M | Buy |
360,117
+52,700
| +17% | +$5.01M | 0.26% | 100 |
|
|
2022
Q1 | $36.2M | Buy |
307,417
+105
| +0% | +$12.4K | 0.24% | 110 |
|
|
2021
Q4 | $39.8M | Buy |
307,312
+75,174
| +32% | +$9.74M | 0.25% | 108 |
|
|
2021
Q3 | $26.3M | Sell |
232,138
-51,000
| -18% | -$5.77M | 0.17% | 154 |
|
|
2021
Q2 | $29.3M | Buy |
283,138
+139,979
| +98% | +$14.5M | 0.19% | 142 |
|
|
2021
Q1 | $12M | Sell |
143,159
-47,701
| -25% | -$3.99M | 0.08% | 310 |
|
|
2020
Q4 | $17.4M | Buy |
+190,860
| New | +$17.4M | 0.12% | 210 |
|
|
2020
Q3 | – | Sell |
-185,700
| Closed | -$12.8M | – | 1134 |
|
|
2020
Q2 | $12.8M | Hold |
185,700
| – | – | 0.1% | 255 |
|
|
2020
Q1 | $11.7M | Buy |
+185,700
| New | +$11.7M | 0.1% | 249 |
|
|
2019
Q4 | – | Sell |
-369,000
| Closed | -$27M | – | 1114 |
|
|
2019
Q3 | $27M | Buy |
369,000
+21,000
| +6% | +$1.54M | 0.18% | 166 |
|
|
2019
Q2 | $21.4M | Sell |
348,000
-60,300
| -15% | -$3.71M | 0.14% | 196 |
|
|
2019
Q1 | $26M | Buy |
408,300
+134,700
| +49% | +$8.59M | 0.16% | 182 |
|
|
2018
Q4 | $14M | Buy |
273,600
+6,000
| +2% | +$306K | 0.1% | 288 |
|
|
2018
Q3 | $15.5M | Buy |
267,600
+22,800
| +9% | +$1.32M | 0.09% | 307 |
|
|
2018
Q2 | $11.9M | Buy |
244,800
+13,200
| +6% | +$641K | 0.07% | 351 |
|
|
2018
Q1 | $10.8M | Buy |
+231,600
| New | +$10.8M | 0.06% | 367 |
|